SITE007-0147

SITE007 (JPN) › SITE007-0147

SITE007-0147

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2026-02-21

enrolled

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-01-30 (study day 149); relationship: NOT RELATED

moderate assessed

Grade 2 Colitis — outcome: RECOVERED/RESOLVED; onset 2022-11-15 (study day 73); relationship: RELATED

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.